Eli Lilly & Co

Indianapolis, IN, United States

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Eli Lilly & Co

FDA Drug Class III Terminated

ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA.

November 8, 2018 Eli Lilly & Co 9,380 vials units